Y79 |
Apoptosis Assay |
1-50 nM |
12/24 h |
induced apoptosis which can be enhanced by HT |
24366665 |
WER-Rb-1 |
Apoptosis Assay |
1-50 nM |
12/24 h |
induced apoptosis which can be enhanced by HT |
24366665 |
SF188 |
Growth Inhibition Assay |
10-100 nM |
24-96 h |
inhibits cell growth in both time- and concentration- depedent manner |
23887645 |
T98G |
Growth Inhibition Assay |
10-100 nM |
24-96 h |
inhibits cell growth in concentration- depedent manner |
23887645 |
MCF7 |
Function Assay |
100 nM |
1 h |
reduces the induction of Greb1, Sgk1, Ps2, Serpina3, and Wisp2 |
23770244 |
MDA-MB-468 |
Apoptosis Assay |
1/5/10 nM |
24/48/72 h |
induces apoptosis in a dose-dependent manner |
23144294 |
MCF10A |
Apoptosis Assay |
1/5/10 nM |
24/48/72 h |
induces apoptosis in a dose-dependent manner |
23144294 |
Huh-7 |
Growth Inhibition Assay |
1/10/100/1000 nM |
48 h |
decreases the cell viability dose-dependently |
22745587 |
Daoy |
Growth Inhibition Assay |
1.875-240 nM |
72 h |
IC50=5 nM |
22390279 |
ONS-76 |
Growth Inhibition Assay |
1.875-240 nM |
72 h |
IC50=7.5 nM |
22390279 |
SUM 149 |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
MDA-MB-231 |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
HR5 |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
BT-474-M1 |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
AU565 |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
T47D |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
MCF7 |
Growth Inhibition Assay |
0-100 nM |
72 h |
inhibits the cell viability in a dose-dependent mannar |
22309939 |
HCT116p53(+/+) |
Growth Inhibition Assay |
10-1000 nM |
24/48 h |
inhibits cell proliferation completely at 25 nM |
22262171 |
HCT116p53(-/-) |
Growth Inhibition Assay |
10-1000 nM |
24/48 h |
inhibits cell proliferation completely at 25 nM |
22262171 |
HeLa |
Growth Inhibition Assay |
10-100 nM |
48 h |
IC50=52.9 nM |
22080235 |
HeLa |
Growth Inhibition Assay |
10-100 nM |
72 h |
IC50=50.5 nM |
22080235 |
786-O |
Growth Inhibition Assay |
5-80 nM |
96 h |
suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM |
21642374 |
A498 |
Growth Inhibition Assay |
5-80 nM |
96 h |
suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM |
21642374 |
ACHN |
Growth Inhibition Assay |
5-80 nM |
96 h |
suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM |
21642374 |
Caki-1 |
Growth Inhibition Assay |
5-80 nM |
96 h |
suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM |
21642374 |
SN12C |
Growth Inhibition Assay |
5-80 nM |
96 h |
suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM |
21642374 |
HMC-1.1 |
Growth Inhibition Assay |
1-1000 nM |
72 h |
inhibits the cell proliferation in a dose-dependent manne |
21242189 |
HMC-1.2 |
Growth Inhibition Assay |
1-1000 nM |
72 h |
inhibits the cell proliferation in a dose-dependent manne |
21242189 |
C2 |
Growth Inhibition Assay |
1-1000 nM |
72 h |
inhibits the cell proliferation in a dose-dependent manne |
21242189 |
CHP-212 |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
IMR-32 |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
Kelly |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
SH-EP |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
SH-SY5Y |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
SK-N-AS |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
SK-N-BE |
Growth Inhibition Assay |
1-125 nM |
24-120 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
21169242 |
KG1 |
Growth Inhibition Assay |
1/10/100 nM |
72 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
19458358 |
U937 |
Growth Inhibition Assay |
1/10/100 nM |
72 h |
inhibits the cell proliferation in both time- and dose-dependent manne |
19458358 |
CAL62 |
Growth Inhibition Assay |
0.1-100 nM |
72 h |
EC50=1.4 nM |
19223553 |
OCUT-1 |
Growth Inhibition Assay |
0.1-100 nM |
72 h |
EC50=2.3 nM |
19223553 |
8505C |
Growth Inhibition Assay |
0.1-100 nM |
72 h |
EC50=3.2 nM |
19223553 |
ACT-1 |
Growth Inhibition Assay |
0.1-100 nM |
72 h |
EC50=5.4 nM |
19223553 |
SW1736 |
Growth Inhibition Assay |
0.1-100 nM |
72 h |
EC50=5.6 nM |
19223553 |
DU145 |
Apoptosis assay |
100 nM |
24 hrs |
Induction of apoptosis in human DU145 cells assessed as increase in PARP cleavage at 100 nM after 24 hrs by immunoblotting method |
25685941 |
HeLa |
Function assay |
100 nM |
18 hrs |
Induction of monopolar mitotic spindles in human HeLa cells at 100 nM incubated for 18 hrs by indirect immunofluorescence microscopy |
25685941 |
HeLa |
Apoptosis assay |
100 nM |
24 hrs |
Induction of apoptosis in human HeLa cells assessed as increase in PARP cleavage at 100 nM after 24 hrs by immunoblotting method |
25685941 |
PC3 |
Function assay |
100 nM |
18 hrs |
Induction of monopolar mitotic spindles in human PC3 cells at 100 nM incubated for 18 hrs by indirect immunofluorescence microscopy |
25685941 |
HeLa |
Function assay |
100 nM |
|
Inhibition of PLK1 Thr210 phosphorylation in human HeLa cells at 100 nM by immunoblotting method |
25685941 |
DU145 |
Function assay |
100 nM |
|
Inhibition of PLK1 protein accumulation in human DU145 cells at 100 nM by immunoblotting method |
25685941 |
HeLa |
Function assay |
100 nM |
|
Inhibition of PLK1 protein accumulation in human HeLa cells at 100 nM by immunoblotting method |
25685941 |
DU145 |
Function assay |
100 nM |
|
Inhibition of PLK1 Thr210 phosphorylation in human DU145 cells at 100 nM by immunoblotting method |
25685941 |
JURKAT |
Growth Inhibition Assay |
|
24 h |
IC50=416.66 nM |
24519995 |
MOLT-4 |
Growth Inhibition Assay |
|
24 h |
IC50=2853.5 nM |
24519995 |
REH |
Growth Inhibition Assay |
|
24 h |
IC50=287.68 nM |
24519995 |
NALM-6 |
Growth Inhibition Assay |
|
24 h |
IC50=34330 nM |
24519995 |
RS 4;11 |
Growth Inhibition Assay |
|
24 h |
IC50=519.05 nM |
24519995 |
697 |
Growth Inhibition Assay |
|
24 h |
IC50=2107.1 nM |
24519995 |
SIL-ALL |
Growth Inhibition Assay |
|
24 h |
IC50=199.77 nM |
24519995 |
CEM |
Growth Inhibition Assay |
|
24 h |
IC50=52.18 nM |
24519995 |
P12 |
Growth Inhibition Assay |
|
24 h |
IC50=39.27 nM |
24519995 |
NALM-16 |
Growth Inhibition Assay |
|
24 h |
IC50=96.28 nM |
24519995 |
JURKAT |
Growth Inhibition Assay |
|
48 h |
IC50=14.84 nM |
24519995 |
MOLT-4 |
Growth Inhibition Assay |
|
48 h |
IC50=26.6 nM |
24519995 |
REH |
Growth Inhibition Assay |
|
48 h |
IC50=44.71 nM |
24519995 |
NALM-6 |
Growth Inhibition Assay |
|
48 h |
IC50=23.26 nM |
24519995 |
RS 4;11 |
Growth Inhibition Assay |
|
48 h |
IC50=164.28 nM |
24519995 |
697 |
Growth Inhibition Assay |
|
48 h |
IC50=305.3 nM |
24519995 |
SIL-ALL |
Growth Inhibition Assay |
|
48 h |
IC50=74.62 nM |
24519995 |
CEM |
Growth Inhibition Assay |
|
48 h |
IC50=24.55 nM |
24519995 |
P12 |
Growth Inhibition Assay |
|
48 h |
IC50=18.46 nM |
24519995 |
NALM-16 |
Growth Inhibition Assay |
|
48 h |
IC50=63.24 nM |
24519995 |
JURKAT |
Growth Inhibition Assay |
|
72 h |
IC50=3.65 nM |
24519995 |
MOLT-4 |
Growth Inhibition Assay |
|
72 h |
IC50=7.39 nM |
24519995 |
REH |
Growth Inhibition Assay |
|
72 h |
IC50=16.01 nM |
24519995 |
NALM-6 |
Growth Inhibition Assay |
|
72 h |
IC50=1.78 nM |
24519995 |
RS 4;11 |
Growth Inhibition Assay |
|
72 h |
IC50=4.38 nM |
24519995 |
697 |
Growth Inhibition Assay |
|
72 h |
IC50=74.28 nM |
24519995 |
SIL-ALL |
Growth Inhibition Assay |
|
72 h |
IC50=7.2 nM |
24519995 |
CEM |
Growth Inhibition Assay |
|
72 h |
IC50=5.42 nM |
24519995 |
P12 |
Growth Inhibition Assay |
|
72 h |
IC50=6.37 nM |
24519995 |
NALM-16 |
Growth Inhibition Assay |
|
72 h |
IC50=77.73 nM |
24519995 |
GBC |
Growth Inhibition Assay |
|
72 h |
IC50=14.78 nM |
21965739 |
GB-CL-1 |
Growth Inhibition Assay |
|
72 h |
IC50=5.22 nM |
21965739 |
Mz-ChA-2 |
Growth Inhibition Assay |
|
72 h |
IC50=3.31 nM |
21965739 |
TGBC1-TKB |
Growth Inhibition Assay |
|
144 h |
IC50=6.72 nM |
21965739 |
Wittier |
Growth Inhibition Assay |
|
72 h |
IC50=3.26 nM |
21965739 |
H-1 |
Growth Inhibition Assay |
|
72 h |
IC50=9.54 nM |
21965739 |
HuH-28 |
Growth Inhibition Assay |
|
72 h |
IC50=11.19 nM |
21965739 |
NEC |
Growth Inhibition Assay |
|
72 h |
IC50=9.98 nM |
21965739 |
REB |
Growth Inhibition Assay |
|
72 h |
IC50=13.51 nM |
21965739 |
CC-LP-1 |
Growth Inhibition Assay |
|
72 h |
IC50=5.84 nM |
21965739 |
CC-SW-1 |
Growth Inhibition Assay |
|
72 h |
IC50=9.55 nM |
21965739 |
EGI-1 |
Growth Inhibition Assay |
|
72 h |
IC50=10.72 nM |
21965739 |
Sk-ChA-1 |
Growth Inhibition Assay |
|
72 h |
IC50=17.2 nM |
21965739 |
TFK-1 |
Growth Inhibition Assay |
|
72 h |
IC50=13.45 nM |
21965739 |
HEK293 |
Function assay |
|
1 hr |
Binding affinity to PLK1 (unknown origin) expressed in HEK293 cells after 1 hr by proprietary competition assay, Ki = 0.00022 μM. |
26191363 |
HEK293T |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against HEK293T cells measured after 72 hrs by CellTiter-Blue assay, IC50 = 0.001 μM. |
28792760 |
MDA-MB-231 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by CellTiter-Blue assay, IC50 = 0.001 μM. |
28792760 |
MM1S |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MM1S cells measured after 72 hrs by CellTiter-Blue assay, IC50 = 0.001 μM. |
28792760 |
TY82 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human TY82 cells after 72 hrs by CCK8 assay, IC50 = 0.001 μM. |
28586718 |
NMC-797 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against BRD4 dependent human NMC-797 cells assessed as cell viability after 3 days by ATPlite assay, IC50 = 0.0107 μM. |
26985285 |
MV4-11 |
Cytotoxicity assay |
|
24 hrs |
Cytotoxicity against human MV4-11 cells after 24 hrs by CellTiter-Blue assay, GI50 = 0.0152 μM. |
26191363 |
BL21(DE3) |
Function assay |
|
60 mins |
Inhibition of recombinant human N-terminal His6-tagged BRD4 expressed in Escherichia coli BL21(DE3) cells using biotinylated histone H4 peptide as substrate after 60 mins by AlphaScreen assay, IC50 = 0.025 μM. |
28195723 |
HuH7 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HuH7 cells after 72 hrs by CCK8 assay, GI50 = 0.028 μM. |
29220793 |
HeLa |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay, GI50 = 0.034 μM. |
29220793 |
HL60 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against BRD4 dependent human HL60 cells assessed as cell viability after 3 days by ATPlite assay, IC50 = 0.0365 μM. |
26985285 |
A549 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human A549 cells after 72 hrs by CCK8 assay, GI50 = 0.057 μM. |
29220793 |
MCF7 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MCF7 cells after 72 hrs by CCK8 assay, GI50 = 0.067 μM. |
29220793 |
K562 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay, GI50 = 0.068 μM. |
29220793 |
MDA-MB-23 |
Function assay |
|
6 hrs |
Inhibition of PLK1 in human MDA-MB-23 cells assessed as decrease in TCTP phosphorylation after 6 hrs by Western blot method, IC50 = 0.1 μM. |
28792760 |
HEK293T |
Function assay |
|
6 hrs |
Inhibition of PLK1 in HEK293T cells assessed as decrease in TCTP phosphorylation after 6 hrs by Western blot method, IC50 = 0.1 μM. |
28792760 |
NCI-H1975 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human NCI-H1975 cells after 72 hrs by CCK8 assay, GI50 = 0.23 μM. |
29220793 |
BL21(DE3) |
Function assay |
|
4 hrs |
Inhibition of JQ1-FITC binding to His6-tagged BRD4-BD1 (unknown origin) expressed in Escherichia coli BL21 (DE3)-codon plus-RIL cells incubated in dark for 4 hrs by fluorescence anisotropy assay, IC50 = 0.25 μM. |
28586718 |
A3-KAW |
Growth Inhibition Assay |
|
|
IC50=0.25341 μM |
SANGER |
CTB-1 |
Growth Inhibition Assay |
|
|
IC50=0.24493 μM |
SANGER |
LB1047-RCC |
Growth Inhibition Assay |
|
|
IC50=0.2441 μM |
SANGER |
OPM-2 |
Growth Inhibition Assay |
|
|
IC50=0.23882 μM |
SANGER |
NCI-H345 |
Growth Inhibition Assay |
|
|
IC50=0.23805 μM |
SANGER |
SIG-M5 |
Growth Inhibition Assay |
|
|
IC50=0.22727 μM |
SANGER |
BC-1 |
Growth Inhibition Assay |
|
|
IC50=0.22616 μM |
SANGER |
GR-ST |
Growth Inhibition Assay |
|
|
IC50=0.21488 μM |
SANGER |
NCI-H1436 |
Growth Inhibition Assay |
|
|
IC50=0.21464 μM |
SANGER |
HH |
Growth Inhibition Assay |
|
|
IC50=0.21405 μM |
SANGER |
GAK |
Growth Inhibition Assay |
|
|
IC50=0.21189 μM |
SANGER |
NCI-H720 |
Growth Inhibition Assay |
|
|
IC50=0.20525 μM |
SANGER |
JiyoyeP-2003 |
Growth Inhibition Assay |
|
|
IC50=0.20477 μM |
SANGER |
EVSA-T |
Growth Inhibition Assay |
|
|
IC50=0.20312 μM |
SANGER |
UACC-257 |
Growth Inhibition Assay |
|
|
IC50=0.19947 μM |
SANGER |
LC4-1 |
Growth Inhibition Assay |
|
|
IC50=0.19502 μM |
SANGER |
KARPAS-299 |
Growth Inhibition Assay |
|
|
IC50=0.19241 μM |
SANGER |
NCI-H2141 |
Growth Inhibition Assay |
|
|
IC50=0.19011 μM |
SANGER |
SNB75 |
Growth Inhibition Assay |
|
|
IC50=0.18824 μM |
SANGER |
L-428 |
Growth Inhibition Assay |
|
|
IC50=0.18813 μM |
SANGER |
NB6 |
Growth Inhibition Assay |
|
|
IC50=0.18566 μM |
SANGER |
COLO-320-HSR |
Growth Inhibition Assay |
|
|
IC50=0.18154 μM |
SANGER |
DOHH-2 |
Growth Inhibition Assay |
|
|
IC50=0.17672 μM |
SANGER |
ARH-77 |
Growth Inhibition Assay |
|
|
IC50=0.17379 μM |
SANGER |
LOXIMVI |
Growth Inhibition Assay |
|
|
IC50=0.16949 μM |
SANGER |
HCE-T |
Growth Inhibition Assay |
|
|
IC50=0.16504 μM |
SANGER |
NCI-H64 |
Growth Inhibition Assay |
|
|
IC50=0.16347 μM |
SANGER |
SU-DHL-1 |
Growth Inhibition Assay |
|
|
IC50=0.16206 μM |
SANGER |
MC116 |
Growth Inhibition Assay |
|
|
IC50=0.16158 μM |
SANGER |
LS-123 |
Growth Inhibition Assay |
|
|
IC50=0.15917 μM |
SANGER |
KINGS-1 |
Growth Inhibition Assay |
|
|
IC50=0.1591 μM |
SANGER |
COLO-684 |
Growth Inhibition Assay |
|
|
IC50=0.15721 μM |
SANGER |
SCLC-21H |
Growth Inhibition Assay |
|
|
IC50=0.15702 μM |
SANGER |
TGBC24TKB |
Growth Inhibition Assay |
|
|
IC50=0.15659 μM |
SANGER |
EM-2 |
Growth Inhibition Assay |
|
|
IC50=0.15467 μM |
SANGER |
SH-4 |
Growth Inhibition Assay |
|
|
IC50=0.15466 μM |
SANGER |
NB5 |
Growth Inhibition Assay |
|
|
IC50=0.15462 μM |
SANGER |
NKM-1 |
Growth Inhibition Assay |
|
|
IC50=0.14906 μM |
SANGER |
COR-L88 |
Growth Inhibition Assay |
|
|
IC50=0.14802 μM |
SANGER |
GB-1 |
Growth Inhibition Assay |
|
|
IC50=0.14526 μM |
SANGER |
CAL-148 |
Growth Inhibition Assay |
|
|
IC50=0.14483 μM |
SANGER |
LP-1 |
Growth Inhibition Assay |
|
|
IC50=0.1424 μM |
SANGER |
MLMA |
Growth Inhibition Assay |
|
|
IC50=0.14167 μM |
SANGER |
NCCIT |
Growth Inhibition Assay |
|
|
IC50=0.13939 μM |
SANGER |
NCI-H747 |
Growth Inhibition Assay |
|
|
IC50=0.137 μM |
SANGER |
KP-N-RT-BM-1 |
Growth Inhibition Assay |
|
|
IC50=0.13612 μM |
SANGER |
HT |
Growth Inhibition Assay |
|
|
IC50=0.13574 μM |
SANGER |
LAMA-84 |
Growth Inhibition Assay |
|
|
IC50=0.13187 μM |
SANGER |
EW-3 |
Growth Inhibition Assay |
|
|
IC50=0.12893 μM |
SANGER |
no-11 |
Growth Inhibition Assay |
|
|
IC50=0.12869 μM |
SANGER |
RPMI-6666 |
Growth Inhibition Assay |
|
|
IC50=0.12743 μM |
SANGER |
SR |
Growth Inhibition Assay |
|
|
IC50=0.12441 μM |
SANGER |
SK-PN-DW |
Growth Inhibition Assay |
|
|
IC50=0.12287 μM |
SANGER |
MZ7-mel |
Growth Inhibition Assay |
|
|
IC50=0.12237 μM |
SANGER |
RPMI-8226 |
Growth Inhibition Assay |
|
|
IC50=0.12052 μM |
SANGER |
KU812 |
Growth Inhibition Assay |
|
|
IC50=0.12044 μM |
SANGER |
TK10 |
Growth Inhibition Assay |
|
|
IC50=0.11728 μM |
SANGER |
K052 |
Growth Inhibition Assay |
|
|
IC50=0.11712 μM |
SANGER |
EoL-1-cell |
Growth Inhibition Assay |
|
|
IC50=0.11672 μM |
SANGER |
NCI-H524 |
Growth Inhibition Assay |
|
|
IC50=0.11274 μM |
SANGER |
BV-173 |
Growth Inhibition Assay |
|
|
IC50=0.11243 μM |
SANGER |
L-363 |
Growth Inhibition Assay |
|
|
IC50=0.11079 μM |
SANGER |
MZ2-MEL |
Growth Inhibition Assay |
|
|
IC50=0.1105 μM |
SANGER |
JAR |
Growth Inhibition Assay |
|
|
IC50=0.10925 μM |
SANGER |
K-562 |
Growth Inhibition Assay |
|
|
IC50=0.10858 μM |
SANGER |
HD-MY-Z |
Growth Inhibition Assay |
|
|
IC50=0.10856 μM |
SANGER |
NCI-SNU-16 |
Growth Inhibition Assay |
|
|
IC50=0.10742 μM |
SANGER |
L-540 |
Growth Inhibition Assay |
|
|
IC50=0.10708 μM |
SANGER |
NCI-H1304 |
Growth Inhibition Assay |
|
|
IC50=0.10594 μM |
SANGER |
NEC8 |
Growth Inhibition Assay |
|
|
IC50=0.10525 μM |
SANGER |
NCI-H526 |
Growth Inhibition Assay |
|
|
IC50=0.1044 μM |
SANGER |
DU-4475 |
Growth Inhibition Assay |
|
|
IC50=0.10407 μM |
SANGER |
BB65-RCC |
Growth Inhibition Assay |
|
|
IC50=0.10294 μM |
SANGER |
NCI-H1882 |
Growth Inhibition Assay |
|
|
IC50=0.09809 μM |
SANGER |
NCI-H2126 |
Growth Inhibition Assay |
|
|
IC50=0.09791 μM |
SANGER |
BC-3 |
Growth Inhibition Assay |
|
|
IC50=0.09662 μM |
SANGER |
Calu-6 |
Growth Inhibition Assay |
|
|
IC50=0.09598 μM |
SANGER |
COR-L279 |
Growth Inhibition Assay |
|
|
IC50=0.09556 μM |
SANGER |
NCI-H446 |
Growth Inhibition Assay |
|
|
IC50=0.09462 μM |
SANGER |
ONS-76 |
Growth Inhibition Assay |
|
|
IC50=0.09276 μM |
SANGER |
NCI-SNU-5 |
Growth Inhibition Assay |
|
|
IC50=0.09258 μM |
SANGER |
MOLT-4 |
Growth Inhibition Assay |
|
|
IC50=0.08983 μM |
SANGER |
DG-75 |
Growth Inhibition Assay |
|
|
IC50=0.08922 μM |
SANGER |
A253 |
Growth Inhibition Assay |
|
|
IC50=0.08822 μM |
SANGER |
KGN |
Growth Inhibition Assay |
|
|
IC50=0.08759 μM |
SANGER |
NCI-H1694 |
Growth Inhibition Assay |
|
|
IC50=0.08744 μM |
SANGER |
LU-134-A |
Growth Inhibition Assay |
|
|
IC50=0.08708 μM |
SANGER |
HEL |
Growth Inhibition Assay |
|
|
IC50=0.08668 μM |
SANGER |
LB831-BLC |
Growth Inhibition Assay |
|
|
IC50=0.08561 μM |
SANGER |
NCI-H510A |
Growth Inhibition Assay |
|
|
IC50=0.08336 μM |
SANGER |
Daudi |
Growth Inhibition Assay |
|
|
IC50=0.08256 μM |
SANGER |
Ramos-2G6-4C10 |
Growth Inhibition Assay |
|
|
IC50=0.08225 μM |
SANGER |
CMK |
Growth Inhibition Assay |
|
|
IC50=0.08225 μM |
SANGER |
KNS-42 |
Growth Inhibition Assay |
|
|
IC50=0.08161 μM |
SANGER |
MOLT-16 |
Growth Inhibition Assay |
|
|
IC50=0.08121 μM |
SANGER |
MONO-MAC-6 |
Growth Inhibition Assay |
|
|
IC50=0.07986 μM |
SANGER |
SW962 |
Growth Inhibition Assay |
|
|
IC50=0.07839 μM |
SANGER |
NCI-H187 |
Growth Inhibition Assay |
|
|
IC50=0.07726 μM |
SANGER |
DMS-114 |
Growth Inhibition Assay |
|
|
IC50=0.07528 μM |
SANGER |
U-266 |
Growth Inhibition Assay |
|
|
IC50=0.07497 μM |
SANGER |
NCI-H1581 |
Growth Inhibition Assay |
|
|
IC50=0.07478 μM |
SANGER |
VA-ES-BJ |
Growth Inhibition Assay |
|
|
IC50=0.07475 μM |
SANGER |
GI-ME-N |
Growth Inhibition Assay |
|
|
IC50=0.07286 μM |
SANGER |
IST-SL2 |
Growth Inhibition Assay |
|
|
IC50=0.07004 μM |
SANGER |
RXF393 |
Growth Inhibition Assay |
|
|
IC50=0.06764 μM |
SANGER |
KS-1 |
Growth Inhibition Assay |
|
|
IC50=0.06748 μM |
SANGER |
NB1 |
Growth Inhibition Assay |
|
|
IC50=0.06613 μM |
SANGER |
CPC-N |
Growth Inhibition Assay |
|
|
IC50=0.06524 μM |
SANGER |
BB30-HNC |
Growth Inhibition Assay |
|
|
IC50=0.06436 μM |
SANGER |
ATN-1 |
Growth Inhibition Assay |
|
|
IC50=0.06345 μM |
SANGER |
MHH-PREB-1 |
Growth Inhibition Assay |
|
|
IC50=0.06319 μM |
SANGER |
RS4-11 |
Growth Inhibition Assay |
|
|
IC50=0.06304 μM |
SANGER |
SF268 |
Growth Inhibition Assay |
|
|
IC50=0.06286 μM |
SANGER |
KM-H2 |
Growth Inhibition Assay |
|
|
IC50=0.06221 μM |
SANGER |
HT-144 |
Growth Inhibition Assay |
|
|
IC50=0.0613 μM |
SANGER |
LB771-HNC |
Growth Inhibition Assay |
|
|
IC50=0.05979 μM |
SANGER |
NALM-6 |
Growth Inhibition Assay |
|
|
IC50=0.05973 μM |
SANGER |
8-MG-BA |
Growth Inhibition Assay |
|
|
IC50=0.05851 μM |
SANGER |
EW-1 |
Growth Inhibition Assay |
|
|
IC50=0.05837 μM |
SANGER |
SK-LMS-1 |
Growth Inhibition Assay |
|
|
IC50=0.05805 μM |
SANGER |
TE-6 |
Growth Inhibition Assay |
|
|
IC50=0.05722 μM |
SANGER |
DEL |
Growth Inhibition Assay |
|
|
IC50=0.05709 μM |
SANGER |
TALL-1 |
Growth Inhibition Assay |
|
|
IC50=0.05708 μM |
SANGER |
KY821 |
Growth Inhibition Assay |
|
|
IC50=0.05632 μM |
SANGER |
TE-12 |
Growth Inhibition Assay |
|
|
IC50=0.05613 μM |
SANGER |
HC-1 |
Growth Inhibition Assay |
|
|
IC50=0.05597 μM |
SANGER |
SJSA-1 |
Growth Inhibition Assay |
|
|
IC50=0.0552 μM |
SANGER |
CTV-1 |
Growth Inhibition Assay |
|
|
IC50=0.05502 μM |
SANGER |
no-10 |
Growth Inhibition Assay |
|
|
IC50=0.05474 μM |
SANGER |
ML-2 |
Growth Inhibition Assay |
|
|
IC50=0.05414 μM |
SANGER |
TGBC1TKB |
Growth Inhibition Assay |
|
|
IC50=0.05405 μM |
SANGER |
KARPAS-45 |
Growth Inhibition Assay |
|
|
IC50=0.05358 μM |
SANGER |
NB17 |
Growth Inhibition Assay |
|
|
IC50=0.05207 μM |
SANGER |
DJM-1 |
Growth Inhibition Assay |
|
|
IC50=0.05142 μM |
SANGER |
TE-5 |
Growth Inhibition Assay |
|
|
IC50=0.05063 μM |
SANGER |
IMR-5 |
Growth Inhibition Assay |
|
|
IC50=0.05021 μM |
SANGER |
MFH-ino |
Growth Inhibition Assay |
|
|
IC50=0.05003 μM |
SANGER |
MS-1 |
Growth Inhibition Assay |
|
|
IC50=0.04701 μM |
SANGER |
LU-139 |
Growth Inhibition Assay |
|
|
IC50=0.04442 μM |
SANGER |
IST-MEL1 |
Growth Inhibition Assay |
|
|
IC50=0.04442 μM |
SANGER |
HCC1599 |
Growth Inhibition Assay |
|
|
IC50=0.04258 μM |
SANGER |
MOLT-13 |
Growth Inhibition Assay |
|
|
IC50=0.04238 μM |
SANGER |
PF-382 |
Growth Inhibition Assay |
|
|
IC50=0.04198 μM |
SANGER |
MZ1-PC |
Growth Inhibition Assay |
|
|
IC50=0.04127 μM |
SANGER |
BL-41 |
Growth Inhibition Assay |
|
|
IC50=0.04125 μM |
SANGER |
KP-N-YS |
Growth Inhibition Assay |
|
|
IC50=0.04085 μM |
SANGER |
OVCAR-4 |
Growth Inhibition Assay |
|
|
IC50=0.04059 μM |
SANGER |
TE-10 |
Growth Inhibition Assay |
|
|
IC50=0.04046 μM |
SANGER |
SW982 |
Growth Inhibition Assay |
|
|
IC50=0.0379 μM |
SANGER |
SK-UT-1 |
Growth Inhibition Assay |
|
|
IC50=0.03774 μM |
SANGER |
A101D |
Growth Inhibition Assay |
|
|
IC50=0.03748 μM |
SANGER |
Becker |
Growth Inhibition Assay |
|
|
IC50=0.03555 μM |
SANGER |
SK-NEP-1 |
Growth Inhibition Assay |
|
|
IC50=0.03499 μM |
SANGER |
ES4 |
Growth Inhibition Assay |
|
|
IC50=0.03463 μM |
SANGER |
NTERA-S-cl-D1 |
Growth Inhibition Assay |
|
|
IC50=0.03399 μM |
SANGER |
NCI-H82 |
Growth Inhibition Assay |
|
|
IC50=0.03343 μM |
SANGER |
ST486 |
Growth Inhibition Assay |
|
|
IC50=0.03337 μM |
SANGER |
NB13 |
Growth Inhibition Assay |
|
|
IC50=0.03316 μM |
SANGER |
LB647-SCLC |
Growth Inhibition Assay |
|
|
IC50=0.03195 μM |
SANGER |
GT3TKB |
Growth Inhibition Assay |
|
|
IC50=0.02953 μM |
SANGER |
ES6 |
Growth Inhibition Assay |
|
|
IC50=0.02881 μM |
SANGER |
BL-70 |
Growth Inhibition Assay |
|
|
IC50=0.02857 μM |
SANGER |
TE-11 |
Growth Inhibition Assay |
|
|
IC50=0.02809 μM |
SANGER |
NCI-H1355 |
Growth Inhibition Assay |
|
|
IC50=0.02783 μM |
SANGER |
KE-37 |
Growth Inhibition Assay |
|
|
IC50=0.02741 μM |
SANGER |
BE-13 |
Growth Inhibition Assay |
|
|
IC50=0.0274 μM |
SANGER |
TE-15 |
Growth Inhibition Assay |
|
|
IC50=0.02738 μM |
SANGER |
ETK-1 |
Growth Inhibition Assay |
|
|
IC50=0.02736 μM |
SANGER |
HCE-4 |
Growth Inhibition Assay |
|
|
IC50=0.02682 μM |
SANGER |
NCI-H1648 |
Growth Inhibition Assay |
|
|
IC50=0.02647 μM |
SANGER |
HUTU-80 |
Growth Inhibition Assay |
|
|
IC50=0.02624 μM |
SANGER |
CCRF-CEM |
Growth Inhibition Assay |
|
|
IC50=0.02543 μM |
SANGER |
TE-1 |
Growth Inhibition Assay |
|
|
IC50=0.02512 μM |
SANGER |
RPMI-8402 |
Growth Inhibition Assay |
|
|
IC50=0.02508 μM |
SANGER |
HOP-62 |
Growth Inhibition Assay |
|
|
IC50=0.0242 μM |
SANGER |
KALS-1 |
Growth Inhibition Assay |
|
|
IC50=0.02338 μM |
SANGER |
KURAMOCHI |
Growth Inhibition Assay |
|
|
IC50=0.02285 μM |
SANGER |
TE-9 |
Growth Inhibition Assay |
|
|
IC50=0.02261 μM |
SANGER |
A388 |
Growth Inhibition Assay |
|
|
IC50=0.02227 μM |
SANGER |
A4-Fuk |
Growth Inhibition Assay |
|
|
IC50=0.02218 μM |
SANGER |
NOS-1 |
Growth Inhibition Assay |
|
|
IC50=0.02093 μM |
SANGER |
LOUCY |
Growth Inhibition Assay |
|
|
IC50=0.0205 μM |
SANGER |
RKO |
Growth Inhibition Assay |
|
|
IC50=0.01987 μM |
SANGER |
OCUB-M |
Growth Inhibition Assay |
|
|
IC50=0.01826 μM |
SANGER |
LXF-289 |
Growth Inhibition Assay |
|
|
IC50=0.0177 μM |
SANGER |
RL95-2 |
Growth Inhibition Assay |
|
|
IC50=0.01738 μM |
SANGER |
SW954 |
Growth Inhibition Assay |
|
|
IC50=0.01705 μM |
SANGER |
IA-LM |
Growth Inhibition Assay |
|
|
IC50=0.01688 μM |
SANGER |
NCI-H1963 |
Growth Inhibition Assay |
|
|
IC50=0.01673 μM |
SANGER |
697 |
Growth Inhibition Assay |
|
|
IC50=0.01668 μM |
SANGER |
CESS |
Growth Inhibition Assay |
|
|
IC50=0.01602 μM |
SANGER |
SNU-C2B |
Growth Inhibition Assay |
|
|
IC50=0.01526 μM |
SANGER |
ES8 |
Growth Inhibition Assay |
|
|
IC50=0.01494 μM |
SANGER |
LS-411N |
Growth Inhibition Assay |
|
|
IC50=0.01407 μM |
SANGER |
GI-1 |
Growth Inhibition Assay |
|
|
IC50=0.01383 μM |
SANGER |
KM12 |
Growth Inhibition Assay |
|
|
IC50=0.01348 μM |
SANGER |
EW-16 |
Growth Inhibition Assay |
|
|
IC50=0.01336 μM |
SANGER |
ALL-PO |
Growth Inhibition Assay |
|
|
IC50=0.013 μM |
SANGER |
LC-2-ad |
Growth Inhibition Assay |
|
|
IC50=0.01093 μM |
SANGER |
TE-8 |
Growth Inhibition Assay |
|
|
IC50=0.00941 μM |
SANGER |
ACN |
Growth Inhibition Assay |
|
|
IC50=0.00843 μM |
SANGER |
PSN1 |
Growth Inhibition Assay |
|
|
IC50=0.00776 μM |
SANGER |
SF126 |
Growth Inhibition Assay |
|
|
IC50=0.25383 μM |
SANGER |
KARPAS-422 |
Growth Inhibition Assay |
|
|
IC50=0.25435 μM |
SANGER |
MEG-01 |
Growth Inhibition Assay |
|
|
IC50=0.25673 μM |
SANGER |
NCI-H209 |
Growth Inhibition Assay |
|
|
IC50=0.26374 μM |
SANGER |
SBC-1 |
Growth Inhibition Assay |
|
|
IC50=0.265 μM |
SANGER |
K5 |
Growth Inhibition Assay |
|
|
IC50=0.26984 μM |
SANGER |
QIMR-WIL |
Growth Inhibition Assay |
|
|
IC50=0.27155 μM |
SANGER |
NMC-G1 |
Growth Inhibition Assay |
|
|
IC50=0.28217 μM |
SANGER |
IST-MES1 |
Growth Inhibition Assay |
|
|
IC50=0.29238 μM |
SANGER |
SW684 |
Growth Inhibition Assay |
|
|
IC50=0.30047 μM |
SANGER |
MV-4-11 |
Growth Inhibition Assay |
|
|
IC50=0.30788 μM |
SANGER |
LAN-6 |
Growth Inhibition Assay |
|
|
IC50=0.31572 μM |
SANGER |
RH-1 |
Growth Inhibition Assay |
|
|
IC50=0.31871 μM |
SANGER |
CP66-MEL |
Growth Inhibition Assay |
|
|
IC50=0.31878 μM |
SANGER |
EC-GI-10 |
Growth Inhibition Assay |
|
|
IC50=0.32987 μM |
SANGER |
GDM-1 |
Growth Inhibition Assay |
|
|
IC50=0.33059 μM |
SANGER |
IST-SL1 |
Growth Inhibition Assay |
|
|
IC50=0.34914 μM |
SANGER |
KMOE-2 |
Growth Inhibition Assay |
|
|
IC50=0.35175 μM |
SANGER |
OS-RC-2 |
Growth Inhibition Assay |
|
|
IC50=0.35544 μM |
SANGER |
HDLM-2 |
Growth Inhibition Assay |
|
|
IC50=0.37814 μM |
SANGER |
DSH1 |
Growth Inhibition Assay |
|
|
IC50=0.38631 μM |
SANGER |
LS-1034 |
Growth Inhibition Assay |
|
|
IC50=0.38954 μM |
SANGER |
LB373-MEL-D |
Growth Inhibition Assay |
|
|
IC50=0.39197 μM |
SANGER |
GOTO |
Growth Inhibition Assay |
|
|
IC50=0.42118 μM |
SANGER |
MRK-nu-1 |
Growth Inhibition Assay |
|
|
IC50=0.42205 μM |
SANGER |
SK-MM-2 |
Growth Inhibition Assay |
|
|
IC50=0.43442 μM |
SANGER |
BOKU |
Growth Inhibition Assay |
|
|
IC50=0.43792 μM |
SANGER |
NOMO-1 |
Growth Inhibition Assay |
|
|
IC50=0.4386 μM |
SANGER |
J-RT3-T3-5 |
Growth Inhibition Assay |
|
|
IC50=0.44878 μM |
SANGER |
COLO-668 |
Growth Inhibition Assay |
|
|
IC50=0.45668 μM |
SANGER |
SF539 |
Growth Inhibition Assay |
|
|
IC50=0.48684 μM |
SANGER |
LB2518-MEL |
Growth Inhibition Assay |
|
|
IC50=0.49703 μM |
SANGER |
TE-441-T |
Growth Inhibition Assay |
|
|
IC50=0.5012 μM |
SANGER |
MDA-MB-134-VI |
Growth Inhibition Assay |
|
|
IC50=0.50921 μM |
SANGER |
SCC-3 |
Growth Inhibition Assay |
|
|
IC50=0.51873 μM |
SANGER |
KLE |
Growth Inhibition Assay |
|
|
IC50=0.52171 μM |
SANGER |
LB2241-RCC |
Growth Inhibition Assay |
|
|
IC50=0.52525 μM |
SANGER |
NCI-H1417 |
Growth Inhibition Assay |
|
|
IC50=0.53435 μM |
SANGER |
NCI-H2081 |
Growth Inhibition Assay |
|
|
IC50=0.58611 μM |
SANGER |
NCI-H1522 |
Growth Inhibition Assay |
|
|
IC50=0.59383 μM |
SANGER |
NCI-H889 |
Growth Inhibition Assay |
|
|
IC50=0.59844 μM |
SANGER |
CGTH-W-1 |
Growth Inhibition Assay |
|
|
IC50=0.60755 μM |
SANGER |
EB-3 |
Growth Inhibition Assay |
|
|
IC50=0.61153 μM |
SANGER |
D-336MG |
Growth Inhibition Assay |
|
|
IC50=0.61791 μM |
SANGER |
LC-1F |
Growth Inhibition Assay |
|
|
IC50=0.62592 μM |
SANGER |
MHH-NB-11 |
Growth Inhibition Assay |
|
|
IC50=0.63801 μM |
SANGER |
SK-N-FI |
Growth Inhibition Assay |
|
|
IC50=0.6391 μM |
SANGER |
NCI-H69 |
Growth Inhibition Assay |
|
|
IC50=0.64879 μM |
SANGER |
SCH |
Growth Inhibition Assay |
|
|
IC50=0.66023 μM |
SANGER |
LS-513 |
Growth Inhibition Assay |
|
|
IC50=0.67259 μM |
SANGER |
CP67-MEL |
Growth Inhibition Assay |
|
|
IC50=0.67596 μM |
SANGER |
GCIY |
Growth Inhibition Assay |
|
|
IC50=0.70363 μM |
SANGER |
SHP-77 |
Growth Inhibition Assay |
|
|
IC50=0.70734 μM |
SANGER |
EHEB |
Growth Inhibition Assay |
|
|
IC50=0.71854 μM |
SANGER |
D-247MG |
Growth Inhibition Assay |
|
|
IC50=0.73232 μM |
SANGER |
Raji |
Growth Inhibition Assay |
|
|
IC50=0.74989 μM |
SANGER |
MPP-89 |
Growth Inhibition Assay |
|
|
IC50=0.75978 μM |
SANGER |
EKVX |
Growth Inhibition Assay |
|
|
IC50=0.79073 μM |
SANGER |
HCC2218 |
Growth Inhibition Assay |
|
|
IC50=0.79131 μM |
SANGER |
KNS-81-FD |
Growth Inhibition Assay |
|
|
IC50=0.81011 μM |
SANGER |
HCC2157 |
Growth Inhibition Assay |
|
|
IC50=0.84951 μM |
SANGER |
BT-474 |
Growth Inhibition Assay |
|
|
IC50=0.88854 μM |
SANGER |
NCI-H748 |
Growth Inhibition Assay |
|
|
IC50=0.912 μM |
SANGER |
EW-24 |
Growth Inhibition Assay |
|
|
IC50=0.92002 μM |
SANGER |
D-263MG |
Growth Inhibition Assay |
|
|
IC50=0.94512 μM |
SANGER |
OMC-1 |
Growth Inhibition Assay |
|
|
IC50=0.96373 μM |
SANGER |
NCI-H2196 |
Growth Inhibition Assay |
|
|
IC50=0.97777 μM |
SANGER |
HAL-01 |
Growth Inhibition Assay |
|
|
IC50=0.99872 μM |
SANGER |
NCI-H2107 |
Growth Inhibition Assay |
|
|
IC50=1.01854 μM |
SANGER |
LB996-RCC |
Growth Inhibition Assay |
|
|
IC50=1.08051 μM |
SANGER |
NCI-H1395 |
Growth Inhibition Assay |
|
|
IC50=1.1067 μM |
SANGER |
CHP-126 |
Growth Inhibition Assay |
|
|
IC50=1.16199 μM |
SANGER |
NB69 |
Growth Inhibition Assay |
|
|
IC50=1.26148 μM |
SANGER |
CAS-1 |
Growth Inhibition Assay |
|
|
IC50=1.34231 μM |
SANGER |
JVM-3 |
Growth Inhibition Assay |
|
|
IC50=1.47855 μM |
SANGER |
DMS-153 |
Growth Inhibition Assay |
|
|
IC50=1.57674 μM |
SANGER |
SK-MEL-2 |
Growth Inhibition Assay |
|
|
IC50=1.71789 μM |
SANGER |
NCI-H1155 |
Growth Inhibition Assay |
|
|
IC50=1.73676 μM |
SANGER |
NCI-H1092 |
Growth Inhibition Assay |
|
|
IC50=1.76182 μM |
SANGER |
LU-165 |
Growth Inhibition Assay |
|
|
IC50=1.86476 μM |
SANGER |
HL-60 |
Growth Inhibition Assay |
|
|
IC50=1.99908 μM |
SANGER |
REH |
Growth Inhibition Assay |
|
|
IC50=2.00582 μM |
SANGER |
JVM-2 |
Growth Inhibition Assay |
|
|
IC50=2.06135 μM |
SANGER |
MN-60 |
Growth Inhibition Assay |
|
|
IC50=2.17308 μM |
SANGER |
SCC-15 |
Growth Inhibition Assay |
|
|
IC50=2.2027 μM |
SANGER |
SNU-C1 |
Growth Inhibition Assay |
|
|
IC50=2.21343 μM |
SANGER |
SK-MEL-1 |
Growth Inhibition Assay |
|
|
IC50=2.32047 μM |
SANGER |
TGW |
Growth Inhibition Assay |
|
|
IC50=2.35027 μM |
SANGER |
CA46 |
Growth Inhibition Assay |
|
|
IC50=2.75967 μM |
SANGER |
NCI-H23 |
Growth Inhibition Assay |
|
|
IC50=2.80791 μM |
SANGER |
MMAC-SF |
Growth Inhibition Assay |
|
|
IC50=2.86628 μM |
SANGER |
NCI-H2171 |
Growth Inhibition Assay |
|
|
IC50=3.03448 μM |
SANGER |
A704 |
Growth Inhibition Assay |
|
|
IC50=3.14194 μM |
SANGER |
DB |
Growth Inhibition Assay |
|
|
IC50=3.25576 μM |
SANGER |
NCI-H719 |
Growth Inhibition Assay |
|
|
IC50=3.30384 μM |
SANGER |
MC-CAR |
Growth Inhibition Assay |
|
|
IC50=3.54817 μM |
SANGER |
SIMA |
Growth Inhibition Assay |
|
|
IC50=3.58416 μM |
SANGER |
SW872 |
Growth Inhibition Assay |
|
|
IC50=3.78101 μM |
SANGER |
HCC1187 |
Growth Inhibition Assay |
|
|
IC50=3.78315 μM |
SANGER |
EW-13 |
Growth Inhibition Assay |
|
|
IC50=3.83417 μM |
SANGER |
NCI-SNU-1 |
Growth Inhibition Assay |
|
|
IC50=4.21999 μM |
SANGER |
NCI-H226 |
Growth Inhibition Assay |
|
|
IC50=4.33606 μM |
SANGER |
RPMI-8866 |
Growth Inhibition Assay |
|
|
IC50=4.36029 μM |
SANGER |
OCI-AML2 |
Growth Inhibition Assay |
|
|
IC50=4.5523 μM |
SANGER |
LU-65 |
Growth Inhibition Assay |
|
|
IC50=4.93033 μM |
SANGER |
SK-N-DZ |
Growth Inhibition Assay |
|
|
IC50=5.63465 μM |
SANGER |
NB14 |
Growth Inhibition Assay |
|
|
IC50=5.97135 μM |
SANGER |
COLO-829 |
Growth Inhibition Assay |
|
|
IC50=6.33359 μM |
SANGER |
MHH-CALL-2 |
Growth Inhibition Assay |
|
|
IC50=6.51508 μM |
SANGER |
NCI-H1770 |
Growth Inhibition Assay |
|
|
IC50=6.66904 μM |
SANGER |
ECC4 |
Growth Inhibition Assay |
|
|
IC50=6.82179 μM |
SANGER |
A498 |
Growth Inhibition Assay |
|
|
IC50=6.87192 μM |
SANGER |
DMS-79 |
Growth Inhibition Assay |
|
|
IC50=7.04512 μM |
SANGER |
P30-OHK |
Growth Inhibition Assay |
|
|
IC50=7.21906 μM |
SANGER |
D-502MG |
Growth Inhibition Assay |
|
|
IC50=7.9836 μM |
SANGER |
RCC10RGB |
Growth Inhibition Assay |
|
|
IC50=8.0628 μM |
SANGER |
U-698-M |
Growth Inhibition Assay |
|
|
IC50=8.29226 μM |
SANGER |
BB49-HNC |
Growth Inhibition Assay |
|
|
IC50=9.42265 μM |
SANGER |
ES1 |
Growth Inhibition Assay |
|
|
IC50=9.68956 μM |
SANGER |
MFM-223 |
Growth Inhibition Assay |
|
|
IC50=10.9927 μM |
SANGER |
C2BBe1 |
Growth Inhibition Assay |
|
|
IC50=11.3523 μM |
SANGER |
EB2 |
Growth Inhibition Assay |
|
|
IC50=12.6881 μM |
SANGER |
C8166 |
Growth Inhibition Assay |
|
|
IC50=13.8303 μM |
SANGER |
ES3 |
Growth Inhibition Assay |
|
|
IC50=13.9977 μM |
SANGER |
NCI-H1650 |
Growth Inhibition Assay |
|
|
IC50=16.3765 μM |
SANGER |
Mo-T |
Growth Inhibition Assay |
|
|
IC50=17.4029 μM |
SANGER |
NB7 |
Growth Inhibition Assay |
|
|
IC50=17.7467 μM |
SANGER |
ES7 |
Growth Inhibition Assay |
|
|
IC50=19.5507 μM |
SANGER |
ES5 |
Growth Inhibition Assay |
|
|
IC50=21.7671 μM |
SANGER |
MSTO-211H |
Growth Inhibition Assay |
|
|
IC50=21.8858 μM |
SANGER |
U-87-MG |
Growth Inhibition Assay |
|
|
IC50=25.1966 μM |
SANGER |
THP-1 |
Growth Inhibition Assay |
|
|
IC50=29.7201 μM |
SANGER |
NB10 |
Growth Inhibition Assay |
|
|
IC50=30.2694 μM |
SANGER |
NH-12 |
Growth Inhibition Assay |
|
|
IC50=33.2017 μM |
SANGER |
COLO-824 |
Growth Inhibition Assay |
|
|
IC50=34.1006 μM |
SANGER |
SKM-1 |
Growth Inhibition Assay |
|
|
IC50=37.8422 μM |
SANGER |
NCI-H1838 |
Growth Inhibition Assay |
|
|
IC50=38.3797 μM |
SANGER |
RL |
Growth Inhibition Assay |
|
|
IC50=39.2477 μM |
SANGER |
COLO-800 |
Growth Inhibition Assay |
|
|
IC50=40.0773 μM |
SANGER |
KG-1 |
Growth Inhibition Assay |
|
|
IC50=40.8955 μM |
SANGER |
TUR |
Growth Inhibition Assay |
|
|
IC50=41.6399 μM |
SANGER |
LNCaP-Clone-FGC |
Growth Inhibition Assay |
|
|
IC50=41.9017 μM |
SANGER |
NCI-H322M |
Growth Inhibition Assay |
|
|
IC50=42.5984 μM |
SANGER |
LNCaP |
Growth Inhibition Assay |
|
|
IC50=91.3 nM |
25505174 |
C4-2 |
Growth Inhibition Assay |
|
|
IC50=8 nM |
25505174 |
G7 |
Growth Inhibition Assay |
|
|
IC50=3.3 nM |
24204733 |
G166 |
Growth Inhibition Assay |
|
|
IC50=7.0 nM |
24204733 |
CB660 |
Growth Inhibition Assay |
|
|
IC50=6.4 nM |
24204733 |
CB1117 |
Growth Inhibition Assay |
|
|
IC50=15.6 nM |
24204733 |
KB-3-1 |
Growth Inhibition Assay |
|
|
IC50=1.48 ± 0.53 nM |
23962445 |
KB-8-5-11 |
Growth Inhibition Assay |
|
|
IC50=5.01 ± 2.01 nM |
23962445 |
KB-C-1 |
Growth Inhibition Assay |
|
|
IC50=16.76 ± 4.51 nM |
23962445 |
KB-V-1 |
Growth Inhibition Assay |
|
|
IC50=281.24 ± 31.57 nM |
23962445 |
OVCAR-8 |
Growth Inhibition Assay |
|
|
IC50=7.19 ± 3.60 nM |
23962445 |
NCI-ADR-RES |
Growth Inhibition Assay |
|
|
IC50=1273.30 ± 191.20 nM |
23962445 |
MCF7 |
Growth Inhibition Assay |
|
|
IC50=5.11 ± 1.47 nM |
23962445 |
MCF7-FLV1000 |
Growth Inhibition Assay |
|
|
IC50=393.18 ± 74.83 nM |
23962445 |
S1 |
Growth Inhibition Assay |
|
|
IC50=24.30 ± 4.75 nM |
23962445 |
S1-M1-80 |
Growth Inhibition Assay |
|
|
IC50=261.06 ± 48.25 nM |
23962445 |
CORL-23/P |
Growth Inhibition Assay |
|
|
IC50=4.38 ± 1.25 nM |
23962445 |
CORL-23/R |
Growth Inhibition Assay |
|
|
IC50=5.16 ± 1.83 nM |
23962445 |
NIH3T3 |
Growth Inhibition Assay |
|
|
IC50=40.60 ± 4.97 nM |
23962445 |
NIH3T3-G185 |
Growth Inhibition Assay |
|
|
IC50=2413.40 ± 423.66 nM |
23962445 |
pcDNA-HEK293 |
Growth Inhibition Assay |
|
|
IC50=2.75 ± 0.67 nM |
23962445 |
MDR19-HEK293 |
Growth Inhibition Assay |
|
|
IC50=85.50 ± 13.67 nM |
23962445 |
R482-HEK293 |
Growth Inhibition Assay |
|
|
IC50=25.97 ± 4.95 nM |
23962445 |
MRP1-HEK293 |
Growth Inhibition Assay |
|
|
IC50=2.99 ± 1.49 nM |
23962445 |
DU145 |
Growth Inhibition Assay |
|
|
IC50∼60 nM |
23884428 |
LNCaP |
Growth Inhibition Assay |
|
|
IC50∼75 nM |
23884428 |
PC3 |
Growth Inhibition Assay |
|
|
IC50∼175 nM |
23884428 |
RT4 |
Growth Inhibition Assay |
|
|
IC50=27.21 nM |
23792639 |
5637 |
Growth Inhibition Assay |
|
|
IC50=45.47 nM |
23792639 |
T24 |
Growth Inhibition Assay |
|
|
IC50=79.12 nM |
23792639 |
KB-V1 |
Growth Inhibition Assay |
|
|
IC50=3.92 μM |
23593196 |
Hec50co |
Growth Inhibition Assay |
|
|
IC50=5 nM |
23146687 |
BL21(DE3) |
Function assay |
|
|
Inhibition of human N-terminal His6-tagged BRD4-BD1 (44 to 168 residues) expressed in Escherichia coli BL21 (DE3) cells using protein thermal shift dye as fluorescence probe by differential scanning fluorimetry, IC50 = 0.025 μM. |
28586718 |
TC32 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells |
29435139 |
U-2 OS |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells |
29435139 |
A673 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells |
29435139 |
Saos-2 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells |
29435139 |
BT-37 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells |
29435139 |
RD |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells |
29435139 |
SK-N-SH |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells |
29435139 |
BT-12 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells |
29435139 |
NB1643 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells |
29435139 |
OHS-50 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells |
29435139 |
BT-12 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells |
29435139 |
LAN-5 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells |
29435139 |
Fibroblast cells |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells |
29435139 |
NB-EBc1 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells |
29435139 |
SK-N-SH |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells |
29435139 |
A673 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells) |
29435139 |
BT-37 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells |
29435139 |
MG 63(6-TG R) |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells |
29435139 |
Fibroblast cells |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells |
29435139 |
OHS-50 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells |
29435139 |
RD |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells |
29435139 |
SJ-GBM2 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells |
29435139 |
SK-N-MC |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells |
29435139 |
NB-EBc1 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells |
29435139 |
LAN-5 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells |
29435139 |
Rh18 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells |
29435139 |
NB1643 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells |
29435139 |
SK-N-MC |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells |
29435139 |
SJ-GBM2 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells |
29435139 |
TC32 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells |
29435139 |
Rh18 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells |
29435139 |
Saos-2 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells |
29435139 |